Список литературы

1. Артамонова В.Г., Шаталов Н.Н. Прфессиональные болезни: Учебник. - 3-є изд., перераб. и допр. - М.: Медицина, 1996. - 432 с.

2. Афанасьева И.С., Спицын В.А. Наследственный полиморфизм глутатион-Бтрасфсразы печени человека в норме и при алкогольном гепатите // Генетика.

3. Бакиров А.Б., Шагарова С.В. Медицина труда сегодня и в XXI веке И Материалы докладов. Экология, здоровье. Взгляд в XXI век, 1999. - Уфа,-С.7-10.

4. Баранов В.С., Баранова Є.В., Иващенко Т.Е. Геном человека и "гены предрасположенности". Введение в предиктивную медицину. Интермедика СПб.: - 2000. - 272 с.

5. Викторова Т.В., Корытина Г.Ф., Макарова О.В., Янбаева Д.Г., Якупова Э.В., Шангареева З.А., Хуснутдинова Э.К. Полиморфизм гена арипамин-И-ацепштрансферазы 2 у народов Волго-Уральского региона // Молекулярная биология. - 2003. - Т.37, №6. - С. 971-974.

6. Вавилин В.А., Часовникова О.Б., Ляховнч В.В. Генетический полиморфизм глутатион-Б-трансферазы Ml и Т1 у детей, больных бронхиальной астмой // Вопросы мед. химии. - 2000. -Т.46, №4. - С. 53- 59.

7. Вавилин В.А., Макарова С.И., Ляхович В.В., Гавалов С.М. Ассоциация полиморфных генов ферментов биотрасформации ксенобиотиков с предрасположенностью к бронхиальной астме у детей с наследственной отягощенностью и без таковой // Генетика. - 2002; - Т.38, №4. - С. 539-545.

8. Вахитова Ю.В., Султанаева З.М., Викторова Т.В., Бикмаева А.Р., Хуснутдинова Э.К. Анализ полиморфизма гена глютатион-Б- трансферазы Ml в популяциях Волго-Уральского региона // Генетика. 2001. - Т.37, №2. - С. 268-270.

9. Гичев Ю.П. Загрязнение окружающей среды и здоровье человека (Печальный опыт России) // Новосибирск, СО РАМН. - 2002. - 230 с. Ю.Головенко Н.Я. Некоторые аспекты биохимии, химии, молекулярной

биологии и генетики цитохрома Р-450 И Проблемы токсикологии. - 2001.-№3.-С. 10-15.

11 .Животовский Л.А. И Популяционная биометрия. Москва. Наука - 1991. -С. 120-137.

12.3имин Ю.В., Сяткин С.П., Березов Т.Т. Молекулярные механизмы метаболитичсской адаптации патологически измененной печени при токсическом гепатите Н Вопр. мед. химии. - 2001. - №3. - С.29-33.

13.Заболевания печени и желчных путей // Шерлок Ш., Дули Д. М. «ГЭОТАР Медицина». 1999. - 860 с.

14. Измеров Н.Ф. Прошлое, настоящее и будущее профпатологии

// Медицина труда и промышленная экология. -

2001.-№ 1.-С.1-9.

15. Иванова Л.А., Безрукавникова Л.М., Кузьмина Л.П. Перспективы биохимического мониторинга генетических эффектов при воздействии на человека вредных факторов производственной среды // Медицина труда и промышленная экология. - 1995. - №5. - С.23-26.

16. Камилов Ф.Х., Гильманов А.Ж., Галимов Ш.Н. Экология и формирование здоровья населения: влияние стойких органических загрязнителей // Биологические и социально-экономические основы формирования здоровья населения Республики Башкортостан. Сб. мат. Республиканской межведомственной научно-практической конференции-семинара. - Уфа. - 2003. - С. 128-139.

П.Каримова Л.К. Научные основы системы оценки и управления рисками в нефтехимической промышленности: Автореф. дисс. на соискание уч. степени д.м.н. - Москва. - 1999. - 48 с.

18. Кузьмина Л.П. Генетико-биохимические исследования в медицине труда // Вест. РАМН. - 2001. - №10. - С.89-91.

19. Кулинский В.И., Колесниченко Л.С. Биологическая роль глутатиона // Успехи современной биологии. - 1990. - Т. 110, № 1 - С. 20-33.

20. Кулинский В.И. Обезвреживание ксенобиотиков // Соросовский образовательный журнал.- 1999. - №1. - С. 8-12.

21. Куценко С.А. Основы токсикологии // СПб., - 2002. - 284 с.

22. Ляхович В.В., Цырлов И.Б. Индукция ферментов метаболизма ксенобиотиков // Новосибирск: Наука, 1981. 240 с.

23. Медико-биологические последствия диоксинов / под ред. Л.М. Карамовой. - «Гилем» - Уфа. 2002, 247с.

24. Мустафина О.Е., Хуснутдинова Э.К. Липидный спектр сыворотки крови в условиях разных антропоэкосистем исследования в Башкортостане.

25. Нафикова А.Х. Комплексное генетико-биохимическое исследование рабочих нефтехимического производства и больных группы «риска» алкогольного гепатита в городе Уфе: Автореф. дисс. на соискание у¹!, степени к.б.н. - Уфа. - 2000. - С.24:

26. Пай Г.В., Кузьмина Л.П., Ковчан О.В., Петрова Н.В., Спицын В.А. Генетические маркеры бронхолегочных заболеваний прфессионального генеза на примере полиморфных генов глутатнон- S-трасферзы Ml и цитохрома Р-4501А1 И Медицинская генетика. - 2003. - Т.2, №5. - С.223-226.

27. Рахманин Ю.А.,. Новиков С.М., Румянцев Г.И. Итоги и перспективы научных исследований по оценке риска для здоровья при воздействии факторов окружающей среды // Итоги и перспективы научных исследований по проблеме экологии человека и гигиены окружающей среды. Сборник материалов научно-практической конференции «Окружающая среда и здоровье населения» - 2002. С.3-26.

28. Рахманин Ю.А., Новиков С.М., Румянцев Г.И. Методологические аспекты оценки риска для здоровья населения при кратковременных и

хронических воздействиях химических веществ, загрязняющих окружающую среду //Гигиена и санитария.- 2001. - № 6.- С. 5-7.

29. Ревазова Ю.А., Журков В.С. Генетические подходы к оценке безопасности факторов среды обитания человека И Вестник РАМН. - 2001.-№10.-С.77-80.

30. Рсвазова Ю.А., Журков В.С. Нестабильность генома человека и действие химичесеких веществ И Экологический риск и здоровье человека: проблемы взаимодействия. Материалы научной сессии Отделения профилактической медицины РАМН 18-19-июня 2002. С. 108-110.

31. Ревич Б.А. Загрязнение окружающей среды и здоровье населения. Введение в экологическую эпидемиологию. // М.: МНЭПУ. 2001. 263 с.

32. Сибиряк С.В., Вахитов В.А., Курчатова Н.Н. Цитохром Р450 и иммунная система // «Гилем» - Уфа, 2003. - 210с.

33. Соколовский В.В. Окислительно-восстановительные процессы в биохимическом механизме неспецифической реакции организма на действие экстремальных факторов внешней среды // Антиоксиданты и адаптация.

34. Спицын В.А., Нафикова А.Х., Спицына Н.Х., Афанасьева И.С. Генетическая предрасположенность к развитию токсического цирроза печени, обусловленного действием алкоголя // Генетика. - 2001. - Т.37, -№5.-С. 698-707.

35. Тарасова Л.А., Кузьмина Л.П., Каспаров А.А. Проблема генетико­биохимических основ индивидуальной чувствительности в медицине труда // Медицина труда и промышленная экология. - 1998. - №4. - С. 1-4.

36. Тиунов Л.А., Кустоев В.В., Трахтенберг И.М., Шафран Л.М. Адаптация и проблемы экологической токсикологии // Экология и токсикология: Сб. мат. 4 пленума правления ВНОТ. - Ярославль, 1990. - С. 15-21.

37. Тиуров Л.А., Иванова В.А. Роль глутатиона в процессах детоксикации И Вест. РАМН СССР. - 1988. - Xsl. - С. 645-252.

38. Худолей В.В., Мизгирев И.В. Экологически опасные факторы. - СПб.: АОЗТ УПФФ, 1996. г-186 с.

39. Чурмантаева С. X. Метаболитические нарушения у рабочих нефтехимического производства, контактирующих с гептилом, пути их коррекции // Медицина труда и промышленная экология. - 2003. - №9. - С. 25-29.

40. Шаяхметова А.М., Сайфетдинова Г.А., Коваленко В.Н., Блажчук И.С., Волошина Е.С., Охрименко В.А., Борщевская М.И. Экспериментальное исследование эффективности препарата биомелан при остром отравлении тетрахлорметаном И Проблемы токсикологии. -2002. - Ха 1. С. 25-30.

41. Abdel-Rahman S.Z., Salama S.A., Au W.W., Hainada F.A. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced cliromosorae aberrations in cultured human lymphocytes // Pharmacogenetics. - 2000. - V.10, №3.-P. 239-49.

42. Abdcl-Rahman S.Z., Ammenheuser M.M., Ward J.B. Human sensitivity to 1,3-butadicnc: role of microsomal epoxide hydrolase polymorphisms // Carcinogenesis. - 2001. - V. 22, №3. - P. 415-23.

43. Abdel-Rahman S.Z., El-Zein R.A., Ammenheuser M.M., Yang Z., Stock T.H., Morandi M., ’Vard J. Jr. Variability in human sensitivity to 1,3- butadiene: influence of the allelic variants of the microsomal epoxide hydrolase gene ZZ Environ.

44. Aklillu E., Persson I., Bertilsson L., Johansson I., Rodrigues F., Ingelman- Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles H J. Pharmacol. Exp. Ther. - 1996.- V. 278.X2l.-P. 441-6.

45. Alexandrie A.K., Warholm M., Carstensen U., Axmon A., Hagmar L., Levin

J.O., Ostinan C., Rannug A. CYPIAI and GSTMI polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure И Carcinogenesis. - 2000.- V. 21, №4.- P. 669-76.

46. Allan J.M., Wild C.P., Rollinson S., Willett E.V., Moorman A.V., Dovey G.J., Roddam P.L., Roman E., Cartwright R.A., Morgan G.J. Polymorphism in glutathione S-transfcrasc Pl is associated with susceptibility to chemotherapy-induced leukemia // Proc. Natl. Acad. Sci. USA.- 2001. - V. 98, №20. -P. 11592-7.

47. Anzcnbachcr P., Anzcnbachcrova E. Cytochromes P450 and metabolism of xenobiotics // Cell. Mol. Life. Sci. - 2001. - V. 58, № 5-6. - P. 737-47.

48. Ayesh R., Idle J. Crothers M., Hetzel M. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer // Nature. - V.312, № 5990. - P. 169-170.

49. Bartsch H., Nair U., Risch A., Rojas M., Wikinan H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers // Cancer. Epidemiol. Biomarkers. Prev. - 2000. - V. 9, № 1. - P. 3-28.

50. Bemardini S., Hirvonen A., Pelin K., Norppa H. Induction of sister chromatid exchange by l,2-epoxy-3-butcnc in cultured human lymphocytes: influence of GSTTl.genotype// Carcinogenesis..- 1998..- V.19, №2. P.377- 80.

51. Binkova B., Topinka J., Mrackova G., Gajdosova D., Vidova P., Stavkova Z., Peterka V., Pilcik T., Rimar V., Dobias L., Farmer P., Sram R. Coke oven workers study: the effect of exposure and GSTMI and NAT2 genotypes on DNA adduct levels in white blood cells and lymphocytes as determined by 32P-postlabelling И Mutat.

52. Board P.G. Biochemical genetics of glutathione-S-transferase in man // Am.

J. Hum. Genet. - 1981. - №33. - 36-43.

53. Board P., Coggan M., Johnston P., Ross V., Suzuki T., Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families // Pharm. Therap. - 1990. - №48. P. 357-369.

54. Bolt H.M., Roos P.H., Thier R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine // Int. Arch. Occup. Environ. Health. - 2003. - V. 7*, №3. - P. 174-85.

55. Blum M., Grant D.M., McBride W., Heim M., Meyer U.A. Human arylamine N-acctyltransferase genes: isolation, chromosomal localization, and functional expression // DNA Cell. Biol. - 1990. -V. 9, №3. - P. 193- 203.

56. Bruning T., Lammert M., Kempkes M., Thier R., Golka K., Bolt H.M. Influence of polymorphisms of GSTMl and GSTTI for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene // Arch. Toxicol. - 1997. - V.71, №9. - P. 596-9.

57. Butkicwicz D., Grzybowska E., Hemminki K. Modulation of DNA adduct level in human mononuclear white blood cells and granulocytes by CYPIAI, CYP2D6 and GSTMl genetic polymorhisms. // Mutation Research. - 1998. - V. 415. - P. 97-108.

58. Cascorbi I., Drakoulis N., Brockmoller J., Maurer A., Sperling K., Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity // Am. J. Human. Genet. - V. 57, №3. - P. 581-592.

59. Chcn C., Madeleine M.M., Lubinski C., Weiss N.S., Tickman E.W., Daling J.R. Glutathione S-trunsferase Ml genotypes and the risk of anal cancer: a population-based case-control study // Cancer Epidemiol. Biomarkers. Prev. - 1996. - V.5,№12. - P. 985 - 991.

60. Chen C.-L., Liu Q., Relling M.V. Simultaneous characterization of glutathione S-transferase Ml and T1 polymorphisms by polymerase chain

reaction in American whites and blacks // Pharmacogenetics. - 1996. - V.6, №2. -P. 187-191.

61. Chen C., Cook L.S., Li X.Y., Hallagan S., Madeleine M.M., Daling J.R., Weiss N.S. CYP2D6 genotype and the incidence of anal and vulvar cancer // Cancer Epidemiol. Biomarkers. Prev. - 1999. - V.8, №4. - P.317-21.

62. Crcspi C.L., Penman B.W., Gelboin H.V., Gonzalez FJ. A tobacco smoke- derived nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6 // Carcinogenesis. - 1991. - V.12, №7. - P. 1197-201.

63. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., Garte S.J. Functional significance of different human CYPIAI genotypes // Carcinogenesis. - 1994. - V.15,№12. P. 2961-3.

64. Dahl M.L., Yue Q.Y., Roh H.K., Johansson I., Sawe J., Sjoqvist F., Bertilsson L. Genetic analysts of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects И Pharmacogenetics. - 1995. - V.5, №3. - P. 159-64.

65. Daly A.K. Pharmacogenetics of the major polymorphic metabolizing enzymes // Fundam. Clin. Pharmacol. - 2003. - V.17, №1. - P. 27-41.

66. De Palma G., Manini P., Mozzoni P., Andreoli R., Bergamaschi E., Cavazzini S.,. Franchini I., Mutti A. Polymorphism of xenobiotic- metabolizing enzymes and excretion of styrene-specific mcrcapturic acids // Chcm. Res. Toxicol. - 2001. - V. 14, №10. P. 1393-400.

67. Dcgtyarenko K.N., Archakov A.I. Molecular evolution of P450 superfamily and P450-containing monooxygenase systems // FEBS Lett. - 1993. - V.l I, №332. - P. 1-8.

68. Doll M.A., Jiang W., Deitz A.C., Rustan T.D., Hein D.W. Identification of a novel allele at the human NAT1 acetyltransferase locus // Biochein. Biophys. Res. Commun. - 1997. - V.28, № 233. - P. 584-91.

69. Eaton D.L., Bammer Th.K. Concise review glutathioe S-trasferases and their significance to toxicology H Toxicological, sciences. - 1999. - V.49, - P. 156- 164.

70. Egan K.M., Cai Q„ Shu X.O., Jin F., Zhu T.L., Dai Q., Gao Y.T., Zheng W. Genetic polymorphisms in GSTMI, GSTPI, and GSTTl and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta­analysis // Cancer. Epidemiol. Biomarkers, prev. - 2004. - V.13, №2. P. 197-204.

71. E1-Zein R., Zwischenberger J.B., Wood T.G., Abdel-Rahman S.Z., Brekelbaum C., Au W.W. Combined genetic polymorphism and risk for development of lung cancer// Mutat. Res. - 1997. - V. 381, №2. - P. 189- 200.

72. Gao Y., Zhang Q. Polymorphisms of the GSTMI and CYP2D6 genes associated with susceptibility to lung cancer in Chinese // Mutat. res. - 1999. - V.444, № 2. - P.441 -449.

73. Gattas G.J., Kato M., Soares-Vieira J.A., Siraque M.S., Kohler P., Gomes L., Rego M.A., Bydlowski S.P. Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population It Braz. j. Med. Biol. Res. - 2004. - V. 37, №4. - P. 451-8.

74. Carere A., Andreoli C., Galati R., Leopardi P., Marcon F., Rosati M.V., Rossi S., Tomei F., Verdina A., Zijno A., Crcbelli R. Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen // Mutat. Res. - 2002. - V.518, №2. P. 215-24.

75. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutclle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le

Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Pari F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roclandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields PG, Sim E, Sinnet D, Strange RC, Stuckcr 1, Sugimura H, To- Figueras J., Vineis P., Yu M.C., Taioli E. Metabolic Gene Polymorphism Frequencies in Control populations // Cancer Epidemiol Biomarkers Prevention. - 2001. - V. 10, №12. - P. 1239-1248.

76. Georgieva T., Michailova A., Panev T., Popov T. Possibilities to control the health risk of petrochemical workers // Int. Arch. Occup. Environ. Health. - 2002.-№ 75.-P. 21-6.

77. Gilliland F.D., Li Y.F., Saxon A., Diaz-Sanchez D. Effect of glutathione-S- transferase Ml and Pl genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study // Lancet. - 2004.-V. 10, №363.-P. 119-25.

78. Golka K., Prior V., Blaszkcwicz M., Cascorbi I., Schops W., Kierfeld G., Roots I., Bolt H.M. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany // Scand. J. Work. Environ. Health. - 1996. - V.22, №5. - P. 332-8.

79. Gonzalez C.A., Saia N., Capclla G. Genetic susceptibility and gastric cancer risk // Int. J. Cancer. - 2002. - V.100, №3. P. 249-60.

80. Gough A.C., Smith C.A., Howell S.M., Wolf C.R., Bryant S.P., Spurr N.K. Localization of the CYP2D gene locus to human chromosome 22ql 3.1 by polymerase chain reaction, in situ hybridization, and linkage analysis // Genomics. - 1993. V.15, №2. - P. 430-2.

81. Grant D.M., GoodfePow G.H., Sugamori K., Durettc K. Pharmacogenetics of the Human Arylamine N-Acctyltransferases // Pharmacology. - 2000. - V.61,№3. -P. 204-211.

82. Gross M., Kruisselbrink T., Anderson K. et al. 1999. Distribution and Concordance of N-acetyltransferase Genotype and Phenotype in an

American population //Cancer. Epidemiol. Biomarkcrs. Prev. - 1999. - V.8, №8. - P. 683-92.

83. Grzybowska E., Butkiewicz D., Motykicwicz G., Chorazy M. The effect of the genetic polymorphisms of CYPIAI, CYP2D6, GSTMI and GSTP1 on aromatic DNA adduct levels in the population of healthy women // Mutat. Res. - 2000. - V.469, №2. - P. 271-277.

84. Guengerich F.P. Molecular advances for the cytochrome P-450 superfamily // Trends. Pharmacol. Sci. - 1991. V.12, №8. - P. 281-3.

85. Habdous M., Siest G., Herbeth B., Vincent-Viry M., Visvikis S. Glutathione S-transferases genetiv polymorphisms and human diseases: overview of epidemiological studies // Ann. Biol. Clin. - 2004. - V.62, №1. P. 15-24.

86. Hallier E., Langhof T., Dannappcl D., Leutbecher M., Schroder K., Goergens H.W., Muller A., Bolt H.M. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromcthane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes // Arch. Toxicol. - 1993. - V.67, №3. P. 173-8.

87. Hansen A.M., Wallin H., Binderup M.L., Dybdahl M., Autrup H., Loft S., Knudsen L.E. Urinary Г-hydroxypyrene and mutagenicity in bus drivers and mail carriers exposed io urban air pollution in Denmark // Mutat. Res. - 2004 V.557, №1. - P. 7-17.

88. Harada S., Abei M., Tanaka N., Agarwal D. P., Goedde H.W. Liver glutathione S-transferasc polymorphism in Japanese and its pharmacogenetic importance // Hum. Genet. - 1987. - V.75. - P. 322-325.

89. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferasc Pi locus and association with susceptibility to bladder, testicular and prostate cancer//Carcinogenesis. - 1997. V.18,№4. - P. 641-4.

90. Hassett C., Robinson K.B., Beck N.B., Omiecinski C.J. The human microsomal epoxide hydrolase gene (EPHXl): complete nucleotide

sequence and structural characterization И Genomics. - 1994. - V.23, №2. - P. 433-42.

91. Hatagima A. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility // Cad. Saude. Publica. - 2002. - V.18, №2. - P. 357-77.

92. Haufroid V., Buchct J.P., Gardinal S., Lison D. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene // Int. Arch. Occup. Environ. Health. - 2002. -V.75, № 7. - P. 453-8.

93. Hayashi S.I., Watanabe J., Nakachi K., Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYPIAI gene // Nucleic Acids Res. -1991. - V.19, №17. - P. 4797.

94. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5’- flanking region change transcriptional regulation of the human cytochrome P450HE1 gene//J. Biochem. - 1991. - V.l 10,- №4. -P. 559-65.

95. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotcction and drug resistance // Crit. Rev. Biochem. Mol. Biol. - 1995. - V.30, №6. - P. 445-600.

96.IIein D.W., Ferguson RJ., Doll M.A. Molecular genetics of human polymorphic N-acetyltrasnferase enzymatic analysis of 15 recombinant wild-type, mutant and chimeric NAT2 allozymes // Hum. Mol. Genet. - 1994.-№3.-729-734.

97. Hcin D.W., Doll M.A., Fretland A.J. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms // Cancer Epidemiol. Biomarersk. Prevention. - 2000. - №9. - P. 29-42.

98. Hellmold H., Rylander T., Magnusson M., Reihner E., Warner M., Gustafsson J. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties // J. Clin. Endocrinol. Mctab. - 1998. - V.83. №3. - P. 886-95.

99. Hemminki К. DNA adducts and mutations in occupational and environmental biomonitoring // Environ Health Pcrspect. - 1997. - V.105. №4. - P. 823-7.

100. Hickman D., Sim E. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans // Biochcm. Phamacol. -1991. - V.8, №42. P. 1007-1014.

101. Hildebrand C.E., Gonzalez F.J., McBride O.W., Nebert D.W. Assignment of the human 2,3,7,8-tctrachlorodibcnzo-p-dioxin-inducible cytochrome Pl-450 gene to chromosome 15 // Nucleic Acids Res. - 1985. №13. P.2009-2016.

102. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., Linnainmaa K. Inherited GSTMl and NAH defects as concurrent risk modifiers in asbertos-related human malignant mesothelioma // Cancer Res. - 1995. - V.55. - P. 2981 - 2983.

103. Hirvonen A., Saarikoski S.T., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., Vainio H. Glutathione S-transfcrase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders// J. Natl. Cancer Inst. - 1996. - V.88, №24. - P. 1853-6.

104. Hong Y.C., Park H.S., Ha E.H. Influence of genetic susceptibility on the urinary excretion of 8-hydroxydcoxyguanosine of firefighters // Occup. Environ. Med. - 2000. - V.57, №6. - P. 370-5.

105. Hu X., Ji X., Srivastava S.K., Xia H., Awasthi S., Nanduri B., Awasthi Y.C., Zimniak P., Singh S.V. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase Pl- 1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene // Arch. Biochem. Biophys. - 1997. V.345,№1. - P. 32-8.

106. Huang C.Y., Huang K.L., Cheng T.J., Wang J.D., Hsieh L.L. The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function // Arch. Toxicol. - 1997. - V.71, №8. - P. 482-8.

107. Hulla J.E., Miller M.S., Taylor J.A., Hein D.W., Furlong C.E., Omiecinski C.J., Kunkel T.A. Symposium overview: the role of genetic polymorphism and repair deficiencies in environmental disease // Toxicol. Sci. - 1999.-V.51, №2.-317 p.

108. Hassett C., Robinson K.B., Beck N.B., Omiecinski C.J. The human microsomal epoxide* hydrolase gene (EPHXl): complete nucleotide sequence and structural characterization // Genomics. - 1994. - V.23, №2. - P. 433-42.

109. Nishimoto I., Hanaoka T., Sugimura H., Nagura K., Ihara M., Li X.- 1, Arai T., Hamada G. Sh., Luis P., Tsugane K., Tsugane Sh. Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians // Cancer Epidemiology, Biomarkers & Prevention. - 2000. V.9. - P. 675-680.

110. Indulski J.A., Lutz W. Metabolic genotype in relation to individual susceptibility to environmental carcinogens // Int. Arch. Occup. Environ. Health. - 2000. - V.73, №2. - P. 71-85.

111. Inoue K., Yamazaki H;, Shimada T. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and Caucasian subjects for CYP2E1 gene // Arch. Toxicol. - 2000. - V.74. - P. 372-378.

112. Ishii T., Matsuse H., Igarashi, Masuda M., Teramoto S., Ouchhi Y. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase Pl // Am. J. Physiol. Lung. Cell. Mol. Physiol. - 2001. - №280. -P. 1189-1195.

113. Johansson I., Lundqvist E., Bertilsson L., Dahl M.L., Sjoqvist F., Ingclman-Sundbcrg M. Inherited amplification of an active gene in the cytochrome P45O CYP2D locus as a cause of ultrarapid metabolism of debrisoquine // Proc. Natl. Acad. Sci. USA. - 1993. - V.90, №24. - P. 11825- 9.

114. Johansson I., Lundqvist E., Dahl M.L., Ingelman-Sundberg M. PCR- based genotyping for duplicated and deleted CYP2D6 genes // Pharmacogenetics. - 1996. - №4. - P. 351-5.

115. Katoh T., Nagata N., Kuroda Y., Itoh H.,.Kawahara A., Kuroki N., Ookuma R., Bell D.A. Glutathione S-transferase Ml (GSTMI) and T1 (GSTTl) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma// Carcinogenesis. - 1996. - V.l7, K°9. - P. 1855-9.

116. Kolble K. Regional mapping of short tandem repeats on human chromosome 10: cytochrome P450 gene CYP2E, D10S196, D10S220, and D10S225 //Genomics. - 1993. V.18. -P. 702-704.

117. Koizumi A., Nomiyama T., Tsukada M., Wada Y., Omae K., Tanaka

S., Miyauchi H., Imamiya S., Sakurai H. Evidence on N-acetyltransferase allelc-associated metabolism of hydrazine in Japanese workers // J. Occup. Environ. Med. - 1998. - V.40, №3. -P. 217-22.

118. Krajinovic M., Richer Ch., Sinnett H. Genetic polymorphisms of N- acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia // Cancer Epidemiol. Biomarkers Prevention. - 2000. №9. - P. 557-562.

119. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review // Mutat. Res. - 2000. - V.463, J&3. - P. 247-83.

120. Lee K.H., Lee J., Ha M., Choi J.W., Cho S.H., Hwang E.S., Park

C. G., Strickland P.T., Hirvonen A., Kang D. Influence of polymorphism of GSTMI gene on association between glycophorin a mutant frequency and urinary PAH metabolites in incineration workers // J. Toxicol. Environ. Health. - 2002. V.65, Ys5-6. - P. 355-63.

121. Lee K.M., Park S.K., Kim S.U., Doll M.A., Yoo K.Y., Alin S.H., Noh

D. Y., Hirvonen A., Hein D.W., Kang D. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTMI, GSTTl) polymorphisms in breast cancer // Cancer Lett. - 2003. - V.196, №2. - P. 179-86.

122. Lennard M.S., Ramsey L.E., Silas J.H., Tucker G.T., Woods H.F. Protecting the poor metaboliser: clinical consequences of genetic polymorphism of drug oxidation // Pharm. Int. - 1983. - №4. - P. 61-65.

123. Lin J.H., Lu A.Y. Inhibition and induction of cytochrome P450 and the clinical implications // Clin. Pharmacokinet. - 1998. - V.35, №5. - P. 361-90.

124. Lucas D., Ferrara R., Gonzales E., Albores A., Manno M., Berthou F. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from expesure to polluted environments// Toxicol. Lett. - 2001. - V.124, №1-3.-P. 71-81.

125. Ma Q., Lin G., Qin Y., Lu D., Golka K., Geller F., Chen J., Shen J. GSTPI A1578G (Ilel05Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells // Pharmacogenetics. - 2003. - V.13,№7. - P.409-15.

126. Mannervik B., Awasthi Y.C., Board P.G., Hayes J.D., Di Ilio C., Ketterer B., Listowsky I., Morgenstem R., Muramatsu M., Pearson W.R. Nomenclature for human glutathione transferases // Biochcm. J. - 1992. - V.15, №282.-P. 305-6.

127. Марр C.E., Fryer A.A., De Marzo N., Pozzato V., Padoan M., Boschctto P., Strange R.C., Hemmingsen A., Spiteri M.A. Glutathione S- transferase GSTPI is a susceptibility gene for occupational asthma induced by isocyanates // J. Allergy Clin. Immunol. - 2002. - V.109, №5. - P. 867- 72.

128. Mathew C.C. The isolation of high molecular weight eucariotic DNA // Methods in molecular biology / Ed. Walker J.M.N.Y.; Hainan Press. - 1984.-P. 31-34.

129. McGlynn K.A., Rosvold EA., Lustbader E.D., Hu Y., Clapper M.L., Zhou T., Wild C.P., Xia X.L., Baffoe-Bonnie A., Ofori-Adjei D., Susceptibility to hepatocellular carcinoma is associated with genetic

variation in the enzymatic detoxification of aflatoxin BI И Proc. Natl. Acad. Sci. USA.- 1995. - V.92, №6. - P. 2384-2387.

130. Merlo F., Andreassen A., Westen A. Urinary excretion of 1- hydroxypyrene as a marker for exposure urban air levels of polycyclic aromatic hydrocarbons // Cancer Epidem. Biomarkers. Prev. - 1998. - V7, №2.-P. 147-155.

131. Nan H.M., Kim H., Lim H.S., Choi J.K., Kawamoto T., Kang J.W., Lee C.H., Kim Y.D., Kwon E.H. Effects of occupation, lifestyle and genetic polymorphisms of CYPIAI, CYP2E1, GSTMI and GSTTI on urinary 1- hydroxypyrene and 2-naphthol concentrations И Carcinogenesis. - 2001. - V. 22, №5. - P. 787-93.

132. Nebert D.W., Gonzalez F.J. P450 genes: structure, evolution, and regulation // Annu. Rev. Biochcm. - 1987. - V.56. P. 945-93.

133. Nebert D.W. Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist? // Am; J. Human. Genet. - 1997.-V.60.-P. 265-271.

134. Nebert D.W. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants // Clin. Chem. Lab. Med. - 2000. - V.38, № 9. - P. 857-61.

135. Neber D.W, Roe A.L. Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer // Sci. Total. Environ. - 2001. - V.274, №1-3.-P. 93-102.

136. Nelson D.R., Koymans L., Kamataki T., Stcgcman J.J., Feyereisen R., Waxman D.J., Waterman M;R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature // Pharmacogenetics. - 1996. - V.6, №1.-P. 1-42.

137. Nelson Ch. P., Kidd L. C. R., Sauvageot J., Isaacs W. B., De Marzo A. M., Groopman J. D., Nelson W. G., Kenslcr Th. W. Protection against 2- hydroxyamino-1 -methy 1-6-phenylimidazo[4,5-b]pyridinc cytotoxicity and

DNA adduct formation in human prostate by glutathione S-transferase Pl // Cancer research. - 2001. - V.161. P. 103-109.

138. Nerurkar P.V.,>Okinaka L., Aoki C., Seifned A., Lum-Jones A., Wilkens L.R., Le Marchand L. CYPIAI, GSTMI, and GSTPI genetic polymorphisms and urinary 1-hydroxy pyrene excretion in non- occupationally exposed individuals // Cancer Epidemiol. Biomarkers Prev. - 2000. - V.9, №10. - P. 1119-22.

139. Oda Y., Kobayashi M., Ooi A., Muroishi Y., Nakanishi I. Genotypes of glutathione S-transferase Ml and N-acetyltransferase 2 in Japanese patients with gastric cancer // Gastric Cancer. - 1999. - V.2, №3. - P. 158- 164.

140. Okino S. T., Qrattrochi L.C., Pendurthi U.R., McBride O.W., Tukey R.H. Characterization of multiple human cytochrome P-450 1 cDNAs: the chromosomal localization of the gene and evidence for alternate RNA splicing И J. Biol. Chem. 1987. - №262. - P. 16072-16079;

141. Orphanides G., Kimber I. Toxicogenetics: Applications and opportunities // Toxicol. Sci. - 2003. - V.75. - P. 1 - 6.

142. Pan G., Hanaoka T., Yamano Y., Нага K., Ichiba M., Wang Y., Zhang J., Feng Y., Shujuan Z., Guan D., Gao G., Liu N., Takahashi K. A study of multiple biomarkers in coke oven workers—a cross-sectional study in China // Carcinogenesis. - 1798. - V.19, №11. - P. 1963-8.

143. Pavanello S., Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms // Mutat. Res. - 2000. - V.463, №3. - P. 285-308.

144. Pavanello S., Siwinska E., Mielzynska D., Clonfero E. GSTMI null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers // Mutat. Res. - 2004. - V.558, №1-2. - P. 53-62.

145. Pearson W.R., Vorachek W.R., Xu S.J., Berger R., Hart I., Vannais D., Patterson D. Identification of class-mu glutathione transferase genes

GSTM1-GSTM5 on human chromosome lpl3 // Am. J. Hum. Genet. - 1993. V.53,№l -P. 220-33.

146. Pearson W.R., Vorachck W.R., Xu S., Berger R., Hart I., Vannais D., Patterson D. Identification of class-mu glutathione transferase genes GSTMl-GSTM5 on human chromosome lpl 3 // Am. J. Hum. Genet. -1993. №53. P. 220-233.

147. Roff D. F., Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: chi 2 and the problem of small samples // Mol. Biol. Evol. - 1989. - №6. - 539-545.

148. Rocha L., Garcia C., Mcndonca A. N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer’s disease // Pharmacogenetics. - 1999. - N29. - P. 9-15.

149. Rojas M., Cascorbi I., Alexandrov K., Kriek E., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. Modulation of benzofa]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYPIAI, GSTMl and GSTTI polymorphism // Carcinogenesis. - 2000. - V.21, №1. P. 35-41.

150. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase Ml and Pl and their significance for lung DNA adduct levels and cancer risk // Carcinogenesis. - 1997. - V.18, №7. P. 1285-9.

151. Santt O., Baranova H., Albuisson E., Bignon Y.J., Lucottc G. Interaction between GSTMl-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease // Eur. J. Neurol. 2004. - V.l 1, №4. - P. 247-51.

152. Sardas S., Сок I., Sardas O.S. Polymorphic N-acetylation capacity in breast cancer patients И Int. J. Cancer. - 1990. - №46. P. 1138-1139.

153. Sarmanova J., Tynkova L., Susova S., Gut I., Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the

population of the Czech Republic // Pharmacogenetics. - 2000. - V.10, №9. P. 781-8.

154. Schlade-Bartusiak K., Rozik K., Laczmanska I., Ramsey D., Sasiadek M. Influence of GSTTI, mEH, CYP2E1 and RAD51 polymorphisms on dicpoxybutane-induced SCE frequency in cultured human lymphocytes И Mutat. Res. -2004. - V.558,№l-2. P. 121-30.

155. Schlesselman J.’ Case-control studies. Design, conduct, analysis // New York, Oxford: Oxford University Press. - 1982. - P. 58-96.

156. Sekine A., Saito A., Iida A. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransfcrase genes NAT1, NAT2, AANAT, ARD1, and L1CAN in the Japanese population // J. Human. Genet. -2001. - №46, P. 314-319.

157. Seidegard J., Рего R. W., Markowitz M. M., Roush G., Miller D. G., Beattie E. J., Seidegard, J., Pcro R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer// Carcinogenesis. - 1986. - №7. - P. 751-753.

158. Seidegard J., Vorachck W. R., Pero R. W., Pearson W. R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion // Proc. Nat. Acad. Sci. - 1988. - №85. - P. 7293-7297.

159. Smith G. D. and Ebrahim Sh. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? И International Journal of Epidemiology. -2003. - V.32. - P. 1-22.

160. Smith C.A., Hapison D.J: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema // Lancet. - 1997. - V.350, №9078. - P. 630-3.

161. Song N.. Tan W., Xing D., Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China // Carcinogenesis. - 2001. - V.22, №1. - P. 11-6.

162. Sonzogni L., Silvestri L., De Silvestri A., Gritti C., Foti L., Zavaglia C., Bottclli R., Mondelli M.U., Civardi E., Silini E.M. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-relatcd liver disease // Hepatology. - 2002. - V.36, №1. - P. 195-201.

163. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S.T., Sram R. Assessment of exposure to butadiene in the process industry // Toxicology. - 1996. - V.l 13, №1-3. - P. 77-83.

164. Spielberg S.P. N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism // J. Pharmacokinet. Biopharm. - 1996. - V. 25, №5. - P. 509-19.

165. Sundberg K., Johansson A.S., Stenberg G., Widersten M;, Seidel A., Mannervik B., Jemstrom B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase Pl-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons // Carcinogenesis: - 1998. - V.19, №3. -P. 433-6.

166. Tan W„ Song N., Wang G.-Q., Liu Q., Tang H.-J., Lin F. K. and D.- X. Impact of generic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases Ml, Tl, and Pl on susceptibility to esophageal cancer among high-risk individuals in China // Cancer Epidemiology Biomarkers & Prevention: - 2000. V.9. - P. 551-556.

167. Tanaka. E. Update: genetic polymorphism of drug metabolizing enzymes in humans //J Clin Pharm Ther. - 1999. - V.24, № 5. - P. 323-9.

168: Taioli E., Ford J., Trachman J., Li Y., Demopoulos R., Garte S. Lung

cancer risk and CYPI AI genotype in African Americans // Carcinogenesis. - 1998.-V.19, №5.-P. 813-7.

169. Teixeira J.P., Gaspar J., Martinho G., Silva SI, Rodrigues S., Mayan O., Martin E., Fanner P.B., Rueff J. Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in genes GSTPI, GSTMI, GSTTl and CYPIAI // Mutat. Res. - 2002. - V.517, № 1-2. - P. 147-55.

170. Teixeira J.P., Gaspar J., Silva S., Torres J., Silva S.N., Azevedo M.C., Neves P., Laffon B., Mendez J., Goncalves C., Mayan O., Farmer P.B., Rueff J. Occupational exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHXI, GSTMl, GSTTI and GSTPI // Toxicology. - 2004. - V. 195, № 2-3. - P. 231-42.

171. Thier R., Wiebel F.A., Hinkel A., Burger A., Bruning T., Morgenroth

K., Senge T., Wilhelm M., Schulz T.G. Species differences in the glutathione transferase GSTTI-1 activity towards the model substrates methyl chloride and dichloromethane in liver and kidney // Arch. Toxicol. - 1998. - V.72, №10. - P. 622-9.

172. Thier R., Lewalter J., Kempkes M., Selinski S., Bruning T., Bolt H.M. Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione transferases GSTTI and GSTMl H Arch. Toxicol. - 1999. -V.73, №4-5. - P. 197-202.

173. Thier R., Golka K., Bruning T., Ko Y., Bolt H.M: Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts // Toxicol. Lett. - 2002. - V.127, №1-3. - P. 321-7.

174. Thier R., Lewalter J., Selinski S., Bolt H.M. Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile // Toxicol. Lett.

- 2002. - V.128, №1-3. - P. 249-55.

175. Thier R., Bruning T., Roos P.H., Rihs H.P., Golka К., Ko Y., Bolt H.M. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes // Int. J. Hyg. Environ. Health. - 2003. - V.206, №3. - P. 149-71.

176. Tuominen R., Baranczewski P., Warholm M. Susceptibility factors and DNA adducts in peripheral blood mononuclear cells of aluminium smelter workers exposed to polycyclic aromatic hydrocarbons // Toxicology.

- 2002. - V. 76, №3. - P. 178 - 186.

177. van Delft J.H., Stecnwinkel M.S., van Asten J.G., de Vogel N., Bruijntjes-Rozier T.C-, Schoutcn T., Cramers P., Maas L., van Herwijnen M.H., van Schooten F., Hopmans P.M. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTMI and GSTTI // Ann. Occup. Hyg. - 2001. - V.45, №5. - P. 395-408.

178. Vatsis K.P., Weber W.W., Bell D.A. Nomenclature for N- acetyltransferases // Pharmacogenetics. -1995. - №5. - P. 1-17.

179. Verkasalo P.K., Kaprio J., Koskenvuo M., Pukkala E. Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-19957/ Int. J. Cancer. - 1999. - V.83, №6. - P. 743-9.

180. Viezzer C., Norppa H., Clonfero E., Gabbani G., Mastrangelo G., Hirvoncn A., Celotti L. Influence of GSTMI, GSTTI, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers // Mutat. Res. - 1999. - V.431, №2. - P. 259-69.

181. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., Hemminki K. Association between genetic polymorphisms and biomarkers in styrene-exposed workers // Mutat. Res. - 2001. - V.482, №1- 2. P. 89-103.

182. Vodicka P., Stetina R., Koskinen M., Soucek P., Vodickova L., Hlavac P., Kuricova M., Nccasova R., Hemminki K. New aspects in the biomonitoring of occupational exposure to styrene // Int. Arch. Occup. Environ. Health. - 2002. - V.75; - P.75-85.

183. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., Huang W., Xia Z., Hu G. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTMI, and GSTTI genes with benzene poisoning // Environ. Health Perspect. - 2002. - V.l 10,№12. - P. 1213-8.

184. Wang Y., Ichiba M., Iyadomi M., Zhang J., Tomokuni K. Effects of genetic polymorphism of metabolic enzymes, nutrition, and lifestyle factors

on DNA adduct formation in lymphocytes // Ind. Health. - 1998. V.36, №4.

- P. 337-46.

185. Wang S.L., Huang J.D., Lai M.D., Liu B.H., Lai M.L. Molecular basis of genetic variation ^Tin debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6 // Clin. Pharmacol: Ther. - 1993. - V.53, №4. - P. 410-8.

186. Wang J., Deng Y., Cheng J., Ding J., Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population // Cancer Lett. - 2003. - V.201, №2. P. 185-93.

187. Watanabe J., Hayashi S., Nakachi K., Imai K., Suda Y., Sekine T., Kawajiri K. Pstl and Rsal RFLPs in complete linkage disequilibrium at the CYP2E gene// Nucleic. Acids Res. - 1990. - V.18,№23. - P. 7194.

188. Watanabe J., Yang J.P., Eguchi H., Hayashi S., Imai K., Nakachi K., Kawajiri K. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population // Jpn. J. Cancer. Res. - 1995. V.86, №3.-P. 245-8.

189. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., Bell D.A. Human glutathione S-transferase Pl polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution // Carcinogenesis. - 1998. - V.19, №2. - P. 275-80.

190. Williams J:A., Martin F.L., Muir G.H., Hewer A., Grover P.L., Phillips D.H. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue // Carcinogenesis. - 2000. - V.21, №9.-P. 1683-9.

191. Willians W., Siera-Torres Carlos H., Cajas-Salazar Nohelia, Salama Salama A. Inheritance of polymorphic metabolizing genes on environmental disease and quality of life // Mutat. Res. Fundam. And Mol. Meeh. Mutagen.

- 1999. - V.428, №1-2. - P.131-140.

192. Wong R.H., Wang J.D., Hsieh L.L., Cheng T.J. XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency

alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers // Arch. Toxicol. - 2003. - V.77, №8. - P. 433-40.

193. Wu M.T., Ыо C.K., Huang S.L., Yeh Y.F., Liu C.L., Mao I.F., Christiani D.C. Modulating influence of cytochrome P-450 MspI polymorphism on scrum liver function profiles in coke oven workers // Occup. Environ. Med. - 1999. V.56, №3. - P. 159-63.

194. Yang M., Koga M., Katoh T., Kawamoto T. A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons // Arch. Environ. Contain. Toxicol. - 1999. - V.36, №1.-P. 99-108.

195. Yu M.W., Pai C.I., Yang S.Y., Hsiao T.J., Chang H.C., Lin S.M., Liaw Y.F., Chen P.J., Chen C.J. Role of N-acetyltransferase polymorphisms in hepatitis В related hepatocellular carcinoma: impact of smoking on risk // Gut. - 2000. V.47, № 5. - P. 703-9.

196. Zhang J., Ichiba M., Feng Y., Pan G., Hanaoka T., Yamano Y., Hara

K., Takahashi K., Tomokuni K. Aromatic DNA adducts in coke-oven workers, in relation to exposure, lifestyle and genetic polymorphism of metabolic enzymes // Int. Arch. Occup. Environ. Health. - 2000. - V.73, № 2. - P. 127-35.

197. Zhang J., Ichiba M., Hara K., Zhang S., Hanaoka T., Pan G., Yamano Y., Takahashi K., Tomokuni K. Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes // Occup. Environ. Med. - 2001. - V.58, №11.- P. 716-21.

198. Zheng Y.X., Chan P., Pan Z.F., Shi N.N., Wang Z.X., Pan J., Liang H.M., Niu Y., Zhou X.R., He F.S. Polymorphism of metabolic genes and susceptibility to occupational chronic manganism // Biomarkers. - 2002. V.7, №4.-P. 337-46.

199. Zhou W., Thurston S.W., Liu G., Xu L.L., Miller D.P., Wain J.C., Lynch T.J., Su L., Cliristiani D.C. The Interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in

different histological subtypes of lung cancer // Cancer Epidemiology Biomarkcrs & Prevention. - 2001. -V.10, P. 461-466.